Bain Capital Life Sciences Investors, LLC Top Holdings and 13F Report (2025) About Bain Capital Life Sciences Investors, LLCInvestment ActivityBain Capital Life Sciences Investors, LLC has $850.10 million in total holdings as of December 31, 2024.Bain Capital Life Sciences Investors, LLC owns shares of 26 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 10.30% of the portfolio was purchased this quarter.About 20.38% of the portfolio was sold this quarter.This quarter, Bain Capital Life Sciences Investors, LLC has purchased 24 new stocks and bought additional shares in 1 stock.Bain Capital Life Sciences Investors, LLC sold shares of 5 stocks and completely divested from 0 stocks this quarter.Largest Holdings NewAmsterdam Pharma $275,481,127Nuvalent $113,292,061Pharvaris $63,325,814Disc Medicine $62,353,900DIANTHUS THERAPEUTICS INC $58,635,613 Largest New Holdings this Quarter Olema Pharmaceuticals $43,551,348 HoldingUPSTREAM BIO INC $37,735,094 Holding Largest Purchases this Quarter Olema Pharmaceuticals 7,470,214 shares (about $43.55M)UPSTREAM BIO INC 2,295,322 shares (about $37.74M)NewAmsterdam Pharma 245,197 shares (about $6.30M) Largest Sales this Quarter Nuvalent 1,250,000 shares (about $97.85M)Disc Medicine 812,235 shares (about $51.50M)Annexon 3,200,679 shares (about $16.42M)DIANTHUS THERAPEUTICS INC 323,716 shares (about $7.06M)Nautilus Biotechnology 241,000 shares (about $404.88K) Sector Allocation Over TimeMap of 500 Largest Holdings ofBain Capital Life Sciences Investors, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorNAMSNewAmsterdam Pharma$275,481,127$6,301,563 ▲2.3%10,719,11032.4%MedicalNUVLNuvalent$113,292,061$97,850,000 ▼-46.3%1,447,26713.3%MedicalPHVSPharvaris$63,325,8140.0%3,303,3817.4%MedicalIRONDisc Medicine$62,353,900$51,495,699 ▼-45.2%983,5007.3%MedicalDIANTHUS THERAPEUTICS INC$58,635,613$7,057,009 ▼-10.7%2,689,7076.9%COMSVRASavara$44,715,9530.0%14,565,4575.3%MedicalOLMAOlema Pharmaceuticals$43,551,348$43,551,348 ▲New Holding7,470,2145.1%MedicalUPSTREAM BIO INC$37,735,094$37,735,094 ▲New Holding2,295,3224.4%COMANNXAnnexon$26,927,724$16,419,483 ▼-37.9%5,249,0693.2%MedicalCIDARA THERAPEUTICS INC$18,898,7900.0%703,0802.2%COM NEWSLDBSolid Biosciences$16,138,3280.0%4,034,5821.9%MedicalKYVERNA THERAPEUTICS INC$12,597,7040.0%3,368,3701.5%COMXFORX4 Pharmaceuticals$12,409,4190.0%16,915,7841.5%MedicalMRSNMersana Therapeutics$12,389,0520.0%8,663,6731.5%MedicalTNGXTango Therapeutics$8,380,1050.0%2,712,0081.0%MedicalAVIRAtea Pharmaceuticals$8,326,8870.0%2,485,6381.0%MedicalRPIDRapid Micro Biosystems$7,591,1040.0%8,434,5600.9%MedicalCABACabaletta Bio$6,267,2160.0%2,760,8880.7%MedicalIPSCCentury Therapeutics$5,464,4650.0%5,410,3610.6%MedicalXLOXilio Therapeutics$4,361,3100.0%4,566,8170.5%MedicalCCCCC4 Therapeutics$4,002,8760.0%1,111,9100.5%MedicalNAUTNautilus Biotechnology$2,955,120$404,880 ▼-12.1%1,759,0000.3%MedicalMRNSMarinus Pharmaceuticals$1,441,2280.0%2,693,3800.2%MedicalNAMSWNewAmsterdam Pharma$1,425,0000.0%100,0000.2%MedicalIVVDInvivyd$797,4010.0%1,799,5950.1%MedicalSYRSSyros Pharmaceuticals$631,9850.0%2,750,1510.1%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
